A new report highlights the key role played by venture capital firms in Europe’s biotechnology sector.
The private equity firm has teamed up with management at PaperPak to complete a buyout of the firm valued at just under E100m.
Venture firms back Cenix Bioscience; Cornerstone backs httprint financing
Siparex Ventures has made six recent acquisitions across its European and US funds, including the acquisition of a Lyon-based fund manager.
Private equity houses in Europe and the US are set to bid against trade buyers to acquire the European satellite operator.
A fall in value of Candover's private equity portfolio valuation has done little to assuage confidence at the firm, which completed five successful realisations in the first half of 2002.
Banexi buys French biotech business; Quester, Advent lead £11.5m biotech deal
As the French market prepares for a possible wave of LBO activity, the LBO division of CDC Ixis Private Equity has made three appointments at its Paris headquarters.
The UK-based private equity house has completed its most important transaction to date, spinning itself out from Zurich Financial Services in a management-led buyout.
The biotechnology investor has held a first close at E125m for its third Biosciences fund, targeting a final close next year at E250m.